US House Panel Passes Bill To Bring More Transparency To Local Coverage Determination Process
Executive Summary
The House Ways and Means Committee advanced legislation backed by the device industry to improve the transparency and accountability of the process Medicare Administrative Contractors use to make local coverage determinations for new medical technology.
You may also be interested in...
Medtech Bill Sponsor Sen. Isakson Retiring At Year’s End
Sen. Johnny Isakson, R-GA, who has sponsored and backed several key pieces of device-industry legislation over the last several years, said on 28 August that he will retire from the US Senate on 31 December 2019, due to health challenges.
CMS Head Verma Unveils Favorable Coding Changes For Medtech, Pharma At MDMA Meeting
The US Centers for Medicare and Medicaid Services will allow device manufacturers to submit requests for HCPCS codes for emerging technology on a semi-annual basis, and drug-makers will be allowed to submit quarterly, CMS chief Seema Verma told an MDMA audience at the industry advocacy group's annual meeting on 2 May.
3 Big Medtech Takeaways From US Midterms
The balance of power will be shifting in Washington, DC, following the Nov. 6 US midterm elections, but that probably will not mean major changes for medtech policies. Here are some key takeaways from the election for device and diagnostics companies.